However, PI3K-mediated activation of downstream effectors, including the serine/threonine kinase AKT and mammalian target of rapamycin (mTOR), is key to promoting cell survival proliferation and differentiation and is aberrantly activated in a variety of human cancers [2, 3]. The gene discussed is MTOR; the disease is cancer.